[Preliminary report on the treatment of ovarian cancer with adriamycin following full conventional treatment (author's transl)].
In 22 cases with advanced ovarian cancer, chemotherapy with Adriamycin was employed. All patients had previous operation, triple drug pulsechemotherapy, intraperitoneal radioactive gold instillations and external radiation. A remission was achieved in 36.4% of the patients. The side effects and complication of treatment with Adriamycin are reported and discussed.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002277:Carcinoma / Q000188:drug therapy; D002291:Carcinoma, Papillary / Q000188:drug therapy; D004317:Doxorubicin / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006106:Granulosa Cell Tumor / Q000188:drug therapy; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D012075:Remission, Spontaneous; D013724:Teratoma / Q000188:drug therapy
D004317:Doxorubicin
Vorläufige Erfahrungen mit Adriamycin bei der Therapie ausbehandelter Ovarialkarzinome